The global digital pathology market, valued at USD 1.03 billion in 2023, is projected to expand at a CAGR of 8.0% from 2024 to 2030. This growth is fueled by the rising prevalence of cancer, the increasing focus on improving workflow efficiency, and the growing demand for faster diagnostic tools. Additionally, rising investments in healthcare, coupled with key players' focus on new launches, the increasing adoption of telepathology, and the growing emphasis on drug discovery and precision medicine, are propelling market growth.
The rising adoption of healthcare IT solutions is driving demand for digital pathology solutions. Organizations are increasingly implementing these solutions to reduce costs, streamline processes, overcome resource constraints, and facilitate efficient content sharing. The growing need for collaborations and the expanding use of digital documentation across various scientific disciplines further drive demand. Moreover, factors such as increased adoption to enhance laboratory efficiency, a surge in teleconsultations, and increased applications in companion diagnostics and drug discovery are expected to contribute to the market's growth.
Gather more insights about the market drivers, restrains and growth of the Digital Pathology Market
Regional Insights:
North America Digital Pathology Market Trends
North America led the overall market in 2023, capturing a 40.7% share. This dominance is attributed to supportive government initiatives fostering technological advancements, substantial R&D investments, growing digital imaging adoption, and the presence of key market players offering innovative solutions. For instance, PathAI's March 2023 launch of AISight, a digital pathology platform, across 13 leading U.S. healthcare institutions signifies the increasing integration of digital pathology into clinical and research settings. Additionally, the rising utilization of digital pathology in academic research and disease diagnosis further accelerates market growth.
Asia Pacific Digital Pathology Market Trends
The Asia Pacific region is poised for the fastest CAGR growth in the electric motor market from 2024 to 2030. This surge is driven by rapid digitalization, increased investments in the medical sector, and rising digital imaging penetration in developing economies. The region's increasing cancer prevalence necessitates innovative treatment options, further accelerating market growth. For instance, Qritive's March 2023 collaboration with Corista, integrating AI into DP3 pathology software, exemplifies initiatives aimed at improving patient care, introducing novel treatments, and reducing laboratory costs.
Browse through Grand View Research's Category Healthcare IT Industry Research Reports.
- The global FemTech market size was estimated at USD 39.29 billion in 2024 and is expected to grow at a CAGR of 16.37% from 2025 to 2030.
- The global move to earn fitness apps market size was estimated at USD 669.9 million in 2024 and is projected to grow at a CAGR of 17.7% from 2025 to 2030.
Key Companies & Market Share Insights
The market is experiencing notable growth owing to rising collaboration, mergers, and product launches. Few notable players in the market includes Leica Biosystems Nussloch GmbH (Danaher), Olympus Corporation, Hamamatsu Photonics, Inc., and F. Hoffmann-La Roche Ltd; CellaVision;Hangzhou Zhiwei Information Technology Co. Ltd. (Morphogo);aetherAI; Morphle Labs, Inc.; Visiopharm A/S; etc.
Key Digital Pathology Companies:
• Leica Biosystems Nussloch GmbH (Danaher)
• Hamamatsu Photonics, Inc.
• Koninklijke Philips N.V.
• Olympus Corporation
• F. Hoffmann-La Roche Ltd.
• Mikroscan Technologies, Inc.
• Inspirata, Inc.
• Epredia (3DHISTECH Ltd.)
• Visiopharm A/S
• Huron Technologies International Inc.
• ContextVision AB
• CellaVision
• HANGZHOU ZHIWEI INFORMATION TECHNOLOGY CO. LTD. (MORPHOGO)
• West Medica Produktions- und Handels- GmbH (West Medica)
• aetherAI
• IBEX (IBEX MEDICAL ANALYTICS)
• SigTuple Technologies Private Limited
• Morphle Labs, Inc
• Bionovation Biotech, Inc.
Order a free sample PDF of the Digital Pathology Market Intelligence Study, published by Grand View Research.
